Statement Of Financial Position [Abstract]

Zealand Pharma - Filing #1417063

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
86,454,000 DKK
85,040,000 DKK
Right-of-use assets
134,994,000 DKK
127,998,000 DKK
Intangible assets other than goodwill
53,790,000 DKK
57,485,000 DKK
Deferred tax assets
13,525,000 DKK
8,370,000 DKK
Cash and cash equivalents
1,129,103,000 DKK
960,221,000 DKK
1,081,060,000 DKK
860,635,000 DKK
Assets
2,067,629,000 DKK
1,761,949,000 DKK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
43,634,000 DKK
39,800,000 DKK
Retained earnings
3,308,402,000 DKK
2,290,253,000 DKK
Share premium
4,250,306,000 DKK
3,472,487,000 DKK
Treasury shares
71,890,000 DKK
1,700,000 DKK
Equity
71,890,000 DKK
3,308,402,000 DKK
927,803,000 DKK
4,250,306,000 DKK
14,155,000 DKK
43,634,000 DKK
2,290,253,000 DKK
39,800,000 DKK
1,700,000 DKK
8,977,000 DKK
3,472,487,000 DKK
1,229,311,000 DKK
0 DKK
2,651,842,000 DKK
1,242,673,000 DKK
1,443,524,000 DKK
1,700,000 DKK
36,055,000 DKK
0 DKK
1,959,177,000 DKK
1,700,000 DKK
1,116,281,000 DKK
30,787,000 DKK
871,983,000 DKK
Liabilities [abstract]
Liabilities
1,139,826,000 DKK
532,638,000 DKK
Equity and liabilities
2,067,629,000 DKK
1,761,949,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.